• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    9.89 Up 2.91(41.69%) Aug 28, 4:00PM EDT
    |After Hours : 9.57 Down 0.32 (3.24%) Aug 28, 7:59PM EDT
    Add to Portfolio
    Prev Close:6.98
    Open:6.90
    Bid:9.57 x 300
    Ask:9.65 x 700
    1y Target Est:8.81
    Beta:1.57728
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:6.90 - 10.07
    52wk Range:4.90 - 10.07
    Volume:38,733,030
    Avg Vol (3m):3,637,240
    Market Cap:1.87B
    P/E (ttm):N/A
    EPS (ttm):-0.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 41.69%1.87B
    PFEDown 1.80%201.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.10
    Quarterly EPS Est (Sep-15) :-0.22
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback